BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34193441)

  • 1. Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity.
    Seclì L; Avalle L; Poggio P; Fragale G; Cannata C; Conti L; Iannucci A; Carrà G; Rubinetto C; Miniscalco B; Hirsch E; Poli V; Morotti A; De Andrea M; Turco E; Cavallo F; Fusella F; Brancaccio M
    Cancer Res; 2021 Sep; 81(18):4794-4807. PubMed ID: 34193441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morgana/CHP-1 is a novel chaperone able to protect cells from stress.
    Michowski W; Ferretti R; Wisniewska MB; Ambrozkiewicz M; Beresewicz M; Fusella F; Skibinska-Kijek A; Zablocka B; Brancaccio M; Tarone G; Kuznicki J
    Biochim Biophys Acta; 2010 Sep; 1803(9):1043-9. PubMed ID: 20493909
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Palumbo V; Tariq A; Borgal L; Metz J; Brancaccio M; Gatti M; Wakefield JG; Bonaccorsi S
    J Cell Sci; 2020 Jan; 133(2):. PubMed ID: 31907206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
    Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
    Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis.
    Ferretti R; Palumbo V; Di Savino A; Velasco S; Sbroggiò M; Sportoletti P; Micale L; Turco E; Silengo L; Palumbo G; Hirsch E; Teruya-Feldstein J; Bonaccorsi S; Pandolfi PP; Gatti M; Tarone G; Brancaccio M
    Dev Cell; 2010 Mar; 18(3):486-95. PubMed ID: 20230755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.
    Baker-Williams AJ; Hashmi F; Budzyński MA; Woodford MR; Gleicher S; Himanen SV; Makedon AM; Friedman D; Cortes S; Namek S; Stetler-Stevenson WG; Bratslavsky G; Bah A; Mollapour M; Sistonen L; Bourboulia D
    Cell Rep; 2019 Aug; 28(7):1894-1906.e6. PubMed ID: 31412254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.
    Ghosh S; Shinogle HE; Garg G; Vielhauer GA; Holzbeierlein JM; Dobrowsky RT; Blagg BS
    ACS Chem Biol; 2015 Feb; 10(2):577-90. PubMed ID: 25402753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.
    Moser C; Lang SA; Kainz S; Gaumann A; Fichtner-Feigl S; Koehl GE; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Nov; 6(11):2868-78. PubMed ID: 18025273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 regulates autophagy and plays a role in cancer therapy.
    Wang B; Chen Z; Yu F; Chen Q; Tian Y; Ma S; Wang T; Liu X
    Tumour Biol; 2016 Jan; 37(1):1-6. PubMed ID: 26432328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Hsp90 and protection of neuronal cells through Nrf2.
    Calderwood SK; Borges TJ; Eguchi T; Lang BJ; Murshid A; Okusha Y; Prince TL
    Biochem Soc Trans; 2021 Nov; 49(5):2299-2306. PubMed ID: 34415306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
    De Nardo D; Masendycz P; Ho S; Cross M; Fleetwood AJ; Reynolds EC; Hamilton JA; Scholz GM
    J Biol Chem; 2005 Mar; 280(11):9813-22. PubMed ID: 15647277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular HSP90 Machineries Build Tumor Microenvironment and Boost Cancer Progression.
    Poggio P; Sorge M; Seclì L; Brancaccio M
    Front Cell Dev Biol; 2021; 9():735529. PubMed ID: 34722515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone.
    Singh JK; Hutt DM; Tait B; Guy NC; Sivils JC; Ortiz NR; Payan AN; Komaragiri SK; Owens JJ; Culbertson D; Blair LJ; Dickey C; Kuo SY; Finley D; Dyson HJ; Cox MB; Chaudhary J; Gestwicki JE; Balch WE
    Cell Chem Biol; 2020 Mar; 27(3):292-305.e6. PubMed ID: 32017918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer.
    Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS
    Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of a Novel Deguelin Derivative, L80, which Disrupts ATP Binding to the C-terminal Domain of Heat Shock Protein 90.
    Lee SC; Min HY; Choi H; Kim HS; Kim KC; Park SJ; Seong MA; Seo JH; Park HJ; Suh YG; Kim KW; Hong HS; Kim H; Lee MY; Lee J; Lee HY
    Mol Pharmacol; 2015 Aug; 88(2):245-55. PubMed ID: 25976766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
    Li J; Richter K; Reinstein J; Buchner J
    Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
    Nam S; Kim H; Hong D; Park JB; Kim SJ
    Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
    Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
    Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for chaperone heterocomplexes containing both Hsp90 and VCP.
    Prince T; Shao J; Matts RL; Hartson SD
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1331-7. PubMed ID: 15883021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.